As of Feb 05
| -0.48 / -1.26%|
The 3 analysts offering 12-month price forecasts for Anika Therapeutics Inc have a median target of 51.00, with a high estimate of 57.00 and a low estimate of 45.00. The median estimate represents a +35.53% increase from the last price of 37.63.
The current consensus among 4 polled investment analysts is to Buy stock in Anika Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.